 |
|
|
| |
AN INTEGRATED ANALYSIS OF 402 COMPENSATED CIRRHOTIC PATIENTS WITH HCV GENOTYPE (GT) 1, 4 or 6 INFECTION TREATED WITH Elbasvir/GRAZOPREVIR
|
| |
| |
Reported by Jules Levin
AASLD Nov 13-17 San Francisco, CA
Ira Jacobson, Eric Lawitz, Paul Kwo,
Christophe Hezode, Cheng-Yuan Peng,
Anita Howe, Peggy Hwang, Janice Wahl, Michael Robertson, Eliav Barr, Barbara Haber
|
| |
|
|
|
|
|
